In a report released today, Anna Andreeva from Piper Sandler maintained a Hold rating on Steven Madden (SHOO – Research Report), with a price ...

NEW YORK--(BUSINESS WIRE)--BTIG announced today that it will host its annual MedTech, Digital Health, Life Science and Diagnostic Tools Conference on Tuesday, February 11 through Wednesday ...

BTIG analyst Ryan Zimmerman upgraded Treace Medical Concepts (TMCI – Research Report) to a Buy today and set a price target of $16.00. The company’s shares closed yesterday at $9.69. Leverage ...

ROCKAWAY, N.J., Feb. 04, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today its participation in the 12 th ...

HOPE has announced plans to assemble a best-in-class global network of interventional psychiatry clinics combining ketamine treatment with transcranial magnetic stimulation, and digital therapeutics ...

Nisa Investment Advisors LLC grew its position in Cipher Mining Inc. (NASDAQ:CIFR – Free Report) by 912.9% during the 4th quarter, according to the company in its most recent filing with the ...

Keefe, Bruyette & Woods lowered their Q4 2025 earnings per share estimates for D.R. Horton in a research report issued on Monday, January 27th. Keefe, Bruyette & Woods analyst J. Rahmani now forecasts ...

Fintel reports that on January 28, 2025, BTIG initiated coverage of Arcturus Therapeutics Holdings (NasdaqGM:ARCT) with a Buy recommendation. Analyst Price Forecast Suggests 331.48% Upside As of ...

On Wednesday, BTIG analyst Carl Reichardt Jr. maintained a Neutral rating on shares of NVR Inc . (NYSE:NVR), while slightly lowering earnings per share (EPS) estimates for the upcoming years.

“Often times during periods of heightened volatility, the market shifts leadership,” said Jonathan Krinsky, chief market technician at BTIG. The momentum long factor (SPMO), (MTUM) had its ...